Intravenous Immunoglobulin Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Intravenous Immunoglobulin Market to 2027 - Global Analysis and Forecasts by Application (Hypogammaglobulinemia, CIPD, Immunodeficiency diseases, Congenital AIDS, Chronic Lymphocytic Leukemia, Myasthenia Gravis, Multifocal motor neuropathy, ITP, Kawasaki disease, Guillain-Barre syndrome and Others); Route of Administration (Intravenous and Subcutaneous)

Report Code: TIPRE00004079 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Intravenous Immunoglobulins are highly purified, sterile specific medical therapy solutions containing gamma globulin G in a concentration of 95% or more. These are manufactured from highly refined pool of human plasma collected from at least 100 donors or more.

MARKET DYNAMICS
The Intravenous Immunoglobulin Market is anticipated to grow in the forecast period owing to driving factors such as rise in global prevalence of autoimmune diseases such as primary humoral immunodeficiency, multiple sclerosis, immune thrombocytopenia purpura, autoimmune hemolytic anemia and Kawasaki syndrome, technological advancements leading to development of new production and purification method, rapid increase in the number of neurological disorders, rise in the global geriatric population and ever increasing number of patients. Nevertheless, increase in investments in research and development of new products is expected to restrain the growth of the market during the forecast period.

MARKET SCOPE
The "Global Intravenous Immunoglobulin Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Intravenous Immunoglobulin Market with detailed market segmentation by Application, Route of Administration and geography. The global Intravenous Immunoglobulin Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Intravenous Immunoglobulin Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Intravenous Immunoglobulin Market is segmented on the basis of Application and Route of Administration. Based on Application the market is segmented into Hypogammaglobulinemia, CIPD, Immunodeficiency diseases, Congenital AIDS, Chronic Lymphocytic Leukemia, Myasthenia Gravis, Multifocal motor neuropathy, ITP, Kawasaki disease, Guillain-Barre syndrome and Others. Based on Route of Administration the market is segmented into Intravenous and Subcutaneous.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Intravenous Immunoglobulin Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Intravenous Immunoglobulin Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Intravenous Immunoglobulin Market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Intravenous Immunoglobulin Market in these regions.

MARKET PLAYERS
The reports cover key developments in the Intravenous Immunoglobulin Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Intravenous Immunoglobulin Market are anticipated to lucrative growth opportunities in the future with the rising demand for Intravenous Immunoglobulin Market in the global market. Below mentioned is the list of few companies engaged in the Intravenous Immunoglobulin Market.

The report also includes the profiles of key Intravenous Immunoglobulin Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Biotest AG
  • Octapharma AG
  • Baxter International Inc.
  • LFB Biotechnologies
  • China Biologics Products Inc
  • Grifols
  • Kedrion Biopharma
  • CSL Behring
  • BDI Pharma
  • Shire Plc
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Intravenous Immunoglobulin Market - By Application
1.3.2 Intravenous Immunoglobulin Market - By Route of Administration
1.3.3 Intravenous Immunoglobulin Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. INTRAVENOUS IMMUNOGLOBULIN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INTRAVENOUS IMMUNOGLOBULIN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INTRAVENOUS IMMUNOGLOBULIN MARKET - GLOBAL MARKET ANALYSIS
6.1. INTRAVENOUS IMMUNOGLOBULIN - GLOBAL MARKET OVERVIEW
6.2. INTRAVENOUS IMMUNOGLOBULIN - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. INTRAVENOUS IMMUNOGLOBULIN MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. HYPOGAMMAGLOBULINEMIA
7.3.1. Overview
7.3.2. Hypogammaglobulinemia Market Forecast and Analysis
7.4. CIPD
7.4.1. Overview
7.4.2. CIPD Market Forecast and Analysis
7.5. IMMUNODEFICIENCY DISEASES
7.5.1. Overview
7.5.2. Immunodeficiency diseases Market Forecast and Analysis
7.6. CONGENITAL AIDS
7.6.1. Overview
7.6.2. Congenital AIDS Market Forecast and Analysis
7.7. CHRONIC LYMPHOCYTIC LEUKEMIA
7.7.1. Overview
7.7.2. Chronic Lymphocytic Leukemia Market Forecast and Analysis
7.8. MYASTHENIA GRAVIS
7.8.1. Overview
7.8.2. Myasthenia Gravis Market Forecast and Analysis
7.9. MULTIFOCAL MOTOR NEUROPATHY
7.9.1. Overview
7.9.2. Multifocal motor neuropathy Market Forecast and Analysis
7.10. ITP
7.10.1. Overview
7.10.2. ITP Market Forecast and Analysis
7.11. KAWASAKI DISEASE
7.11.1. Overview
7.11.2. Kawasaki disease Market Forecast and Analysis
7.12. GUILLAIN-BARRE SYNDROME AND OTHERS
7.12.1. Overview
7.12.2. Guillain-Barre syndrome and Others Market Forecast and Analysis
8. INTRAVENOUS IMMUNOGLOBULIN MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. INTRAVENOUS AND SUBCUTANEOUS.
8.3.1. Overview
8.3.2. Intravenous and Subcutaneous. Market Forecast and Analysis
9. INTRAVENOUS IMMUNOGLOBULIN MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Intravenous Immunoglobulin Market Overview
9.1.2 North America Intravenous Immunoglobulin Market Forecasts and Analysis
9.1.3 North America Intravenous Immunoglobulin Market Forecasts and Analysis - By Application
9.1.4 North America Intravenous Immunoglobulin Market Forecasts and Analysis - By Route of Administration
9.1.5 North America Intravenous Immunoglobulin Market Forecasts and Analysis - By Countries
9.1.5.1 United States Intravenous Immunoglobulin Market
9.1.5.1.1 United States Intravenous Immunoglobulin Market by Application
9.1.5.1.2 United States Intravenous Immunoglobulin Market by Route of Administration
9.1.5.2 Canada Intravenous Immunoglobulin Market
9.1.5.2.1 Canada Intravenous Immunoglobulin Market by Application
9.1.5.2.2 Canada Intravenous Immunoglobulin Market by Route of Administration
9.1.5.3 Mexico Intravenous Immunoglobulin Market
9.1.5.3.1 Mexico Intravenous Immunoglobulin Market by Application
9.1.5.3.2 Mexico Intravenous Immunoglobulin Market by Route of Administration
9.1.5.4 US Intravenous Immunoglobulin Market
9.1.5.4.1 US Intravenous Immunoglobulin Market by Application
9.1.5.4.2 US Intravenous Immunoglobulin Market by Route of Administration
9.2. EUROPE
9.2.1 Europe Intravenous Immunoglobulin Market Overview
9.2.2 Europe Intravenous Immunoglobulin Market Forecasts and Analysis
9.2.3 Europe Intravenous Immunoglobulin Market Forecasts and Analysis - By Application
9.2.4 Europe Intravenous Immunoglobulin Market Forecasts and Analysis - By Route of Administration
9.2.5 Europe Intravenous Immunoglobulin Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Intravenous Immunoglobulin Market
9.2.5.1.1 Germany Intravenous Immunoglobulin Market by Application
9.2.5.1.2 Germany Intravenous Immunoglobulin Market by Route of Administration
9.2.5.2 France Intravenous Immunoglobulin Market
9.2.5.2.1 France Intravenous Immunoglobulin Market by Application
9.2.5.2.2 France Intravenous Immunoglobulin Market by Route of Administration
9.2.5.3 Italy Intravenous Immunoglobulin Market
9.2.5.3.1 Italy Intravenous Immunoglobulin Market by Application
9.2.5.3.2 Italy Intravenous Immunoglobulin Market by Route of Administration
9.2.5.4 Spain Intravenous Immunoglobulin Market
9.2.5.4.1 Spain Intravenous Immunoglobulin Market by Application
9.2.5.4.2 Spain Intravenous Immunoglobulin Market by Route of Administration
9.2.5.5 United Kingdom Intravenous Immunoglobulin Market
9.2.5.5.1 United Kingdom Intravenous Immunoglobulin Market by Application
9.2.5.5.2 United Kingdom Intravenous Immunoglobulin Market by Route of Administration
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Intravenous Immunoglobulin Market Overview
9.3.2 Asia-Pacific Intravenous Immunoglobulin Market Forecasts and Analysis
9.3.3 Asia-Pacific Intravenous Immunoglobulin Market Forecasts and Analysis - By Application
9.3.4 Asia-Pacific Intravenous Immunoglobulin Market Forecasts and Analysis - By Route of Administration
9.3.5 Asia-Pacific Intravenous Immunoglobulin Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Intravenous Immunoglobulin Market
9.3.5.1.1 Australia Intravenous Immunoglobulin Market by Application
9.3.5.1.2 Australia Intravenous Immunoglobulin Market by Route of Administration
9.3.5.2 China Intravenous Immunoglobulin Market
9.3.5.2.1 China Intravenous Immunoglobulin Market by Application
9.3.5.2.2 China Intravenous Immunoglobulin Market by Route of Administration
9.3.5.3 India Intravenous Immunoglobulin Market
9.3.5.3.1 India Intravenous Immunoglobulin Market by Application
9.3.5.3.2 India Intravenous Immunoglobulin Market by Route of Administration
9.3.5.4 Japan Intravenous Immunoglobulin Market
9.3.5.4.1 Japan Intravenous Immunoglobulin Market by Application
9.3.5.4.2 Japan Intravenous Immunoglobulin Market by Route of Administration
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Intravenous Immunoglobulin Market Overview
9.4.2 Middle East and Africa Intravenous Immunoglobulin Market Forecasts and Analysis
9.4.3 Middle East and Africa Intravenous Immunoglobulin Market Forecasts and Analysis - By Application
9.4.4 Middle East and Africa Intravenous Immunoglobulin Market Forecasts and Analysis - By Route of Administration
9.4.5 Middle East and Africa Intravenous Immunoglobulin Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Intravenous Immunoglobulin Market
9.4.5.1.1 South Africa Intravenous Immunoglobulin Market by Application
9.4.5.1.2 South Africa Intravenous Immunoglobulin Market by Route of Administration
9.4.5.2 Saudi Arabia Intravenous Immunoglobulin Market
9.4.5.2.1 Saudi Arabia Intravenous Immunoglobulin Market by Application
9.4.5.2.2 Saudi Arabia Intravenous Immunoglobulin Market by Route of Administration
9.4.5.3 U.A.E Intravenous Immunoglobulin Market
9.4.5.3.1 U.A.E Intravenous Immunoglobulin Market by Application
9.4.5.3.2 U.A.E Intravenous Immunoglobulin Market by Route of Administration
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Intravenous Immunoglobulin Market Overview
9.5.2 South and Central America Intravenous Immunoglobulin Market Forecasts and Analysis
9.5.3 South and Central America Intravenous Immunoglobulin Market Forecasts and Analysis - By Application
9.5.4 South and Central America Intravenous Immunoglobulin Market Forecasts and Analysis - By Route of Administration
9.5.5 South and Central America Intravenous Immunoglobulin Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Intravenous Immunoglobulin Market
9.5.5.1.1 Brazil Intravenous Immunoglobulin Market by Application
9.5.5.1.2 Brazil Intravenous Immunoglobulin Market by Route of Administration
9.5.5.2 Argentina Intravenous Immunoglobulin Market
9.5.5.2.1 Argentina Intravenous Immunoglobulin Market by Application
9.5.5.2.2 Argentina Intravenous Immunoglobulin Market by Route of Administration
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. INTRAVENOUS IMMUNOGLOBULIN MARKET, KEY COMPANY PROFILES
11.1. BIOTEST AG
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. OCTAPHARMA AG
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BAXTER INTERNATIONAL INC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. LFB BIOTECHNOLOGIES
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. CHINA BIOLOGICS PRODUCTS INC
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. GRIFOLS
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. KEDRION BIOPHARMA
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. CSL BEHRING
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. BDI PHARMA
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. SHIRE PLC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

- Biotest AG
- Octapharma AG
- Baxter International Inc.
- LFB Biotechnologies
- China Biologics Products Inc
- Grifols
- Kedrion Biopharma
- CSL Behring
- BDI Pharma
- Shire Plc
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book